The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period for the revised 2018 evidence-based guideline, “Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors.”
Health Organizations Making Strides In Health Equity, AMA Leader Says
NATIONAL HARBOR, Md. — Half of healthcare organizations surveyed have eliminated or are working to eliminate race-based clinical algorithms and decision-making tools that incorrectly use